Anlon Healthcare IPO Details
| IPO Open Date: | August 26, 2025 |
| IPO Close Date: | August 29, 2025 |
| Face Value: | ā¹10 Per Equity Share |
| IPO Price Band: | ā¹86 to ā¹91 Per Share |
| Issue Size: | Approx ā¹121.03 Crores |
| Fresh Issue: | Approx ā¹121.03 Crores |
| Lot Size: | 164 Shares |
| Issue Type: | Book Build IPO |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 10% |
| QIB Quota: | Not more than 75% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Anlon Healthcare IPO Market Lot
The Anlon Healthcare IPO minimum market lot is 164 shares with ā¹14,924 application amount. The retail investors can apply up-to 13 lots with 2,132 shares of ā¹1,94,012Ā amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 164 | ā¹14,924 |
| Retail Maximum | 13 | 2,132 | ā¹1,94,012 |
| S-HNI Minimum | 14 | 2,296 | ā¹2,08,936 |
| B-HNI Minimum | 68 | 11,152 | ā¹10,14,832 |
Anlon Healthcare IPO Dates
The Anlon Healthcare IPO date is August 26 and the close date is August 29. The Anlon Healthcare IPO allotment will be finalized on September 1 and the IPO listing on September 3.
| IPO Open Date: | August 26, 2025 |
| IPO Close Date: | August 29, 2025 |
| Basis of Allotment: | September 1, 2025 |
| Refunds: | September 2, 2025 |
| Credit to Demat Account: | September 2, 2025 |
| IPO Listing Date: | September 3, 2025 |
Promoters of Anlon Healthcare IPO
The promoters of the company are Punitkumar R. rasadia, Meet Atulkumar Vachhani and Mamata punitkumar Rasadia.
About Anlon Healthcare IPO
Anlon Healthcare Limited, founded in 2013, is one of the growing chemical manufacturing companies engaged in the manufacturing of 2 things: 1. high purity advanced pharmaceutical intermediates used as raw materials for making active pharmaceutical ingredients (APIs). 2. APIs are used in medicines like tablets, capsules, ointments, syrups, as well as in nutraceuticals, personal care, and animal health products. Its portfolio consists of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), nutraceutical APIs, and ingredients for personal care and veterinary use.
Moreover, among a few other companies, Anlon Healthcare is an Indian maker of loxoprofen sodium dihydrate, which is an API widely useful to treat severe pain like arthritis, back pain, frozen shoulder, tooth pain, or post-surgery recovery. The company had 105 employees (excluding trainees) and 8 contract workers as of January 31, 2025. As of the date of filing DRHP, the company has 65 commercial products, 28 at the pilot stage, and 49 in laboratory testing.
Anlon Healthcare IPO Company Financial Report
The company reported revenue of ā¹66.69 crores in 2024 against ā¹113.12 crores in 2023. The company reported profit of ā¹9.66 crores in 2024 against profit of ā¹5.82 crores in 2023.
Amount ā¹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ā¹57.54 | ā¹57.64 | ā¹0.11 | ā¹84.97 |
| 2023 | ā¹113.12 | ā¹106.13 | ā¹5.82 | ā¹111.55 |
| 2024 | ā¹66.69 | ā¹56.94 | ā¹9.66 | ā¹128.00 |
| 2025 | ā¹120.46 | ā¹93.57 | ā¹20.52 | ā¹181.30 |
Anlon Healthcare Key Indicators – FY2025
Check Anlon Healthcare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 25.51% |
| ROCE: | 21.93% |
| EBITDA Margin: | 26.88% |
| PAT Margin: | 17.06% |
| Debt to equity ratio: | 0.73 |
| Earning Per Share (EPS): | ā¹6.38 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 25.51% |
| Net Asset Value (NAV): | ā¹20.18 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Kronox Lab Sciences Limited | 5.81 | 26.72 | 32.20 | 17.87 | 91.44 Cr. |
| AMI Organics Limited | 11.91 | 197.70 | 6.47 | 183.05 | 701.37 Cr. |
| Supriya Lifeciences Limited | 14.80 | 49.52 | 14.61 | 101.31 | 581.01 Cr. |
Objects of the Issue
- Funding capital expenditure requirements for Proposed Expansion
- Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company
- Funding the working capital requirements of the Company
- General corporate purposes
Anlon Healthcare IPO Review
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
Anlon Healthcare IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Managers aka Merchant Bankers
- Interactive Financial Services Ltd
Company Address
Anlon Healthcare Ltd.
101/102, Silvercoin Complex,
Opp.Crystal Mall,
Kalawad Road,
Rajkot, Gujarat, 360005
Phone: +91 281 2562538
Email: [email protected]
Website: http://www.anlon.in/
Anlon Healthcare IPO FAQs
What is Anlon Healthcare IPO?
When Anlon Healthcare IPO will open for subscription?
What is Anlon Healthcare IPO Investors Portion?
How to Apply the Anlon Healthcare IPO?
What is Anlon Healthcare IPO Issue Size?
What is Anlon Healthcare IPO Price Band?
What is Anlon Healthcare IPO Lot Size?
What is the Anlon Healthcare IPO Allotment Date?
What is the Anlon Healthcare IPO Listing Date?
Note: The Anlon Healthcare IPO price band and date are officially announced. The (Anlon Healthcare IPO grey market premium) will be added to the IPO GMP page as it will start).
